[
  {
    "ts": "2026-01-11T22:30:00+00:00",
    "headline": "Tempus Achieves Record Total Contract Value Exceeding $1.1 Billion",
    "summary": "CHICAGO, January 11, 2026--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a record Total Contract Value (TCV) of >$1.1 billion as of December 31, 2025. During 2025, Tempus signed data agreements with over 70 customers, spanning both large and mid-sized pharma, including AstraZeneca, GlaxoSmithKline, Bristol Myers Squibb, Pfizer, Novartis, Merck, Abbvie, Daiichi Sankyo, Eli Lilly, Boehringer Ingelheim, and biotechs inc",
    "url": "https://finance.yahoo.com/news/tempus-achieves-record-total-contract-223000270.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "8892092e-f66b-3479-94d4-b3c8001dae8f",
      "content": {
        "id": "8892092e-f66b-3479-94d4-b3c8001dae8f",
        "contentType": "STORY",
        "title": "Tempus Achieves Record Total Contract Value Exceeding $1.1 Billion",
        "description": "",
        "summary": "CHICAGO, January 11, 2026--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a record Total Contract Value (TCV) of >$1.1 billion as of December 31, 2025. During 2025, Tempus signed data agreements with over 70 customers, spanning both large and mid-sized pharma, including AstraZeneca, GlaxoSmithKline, Bristol Myers Squibb, Pfizer, Novartis, Merck, Abbvie, Daiichi Sankyo, Eli Lilly, Boehringer Ingelheim, and biotechs inc",
        "pubDate": "2026-01-11T22:30:00Z",
        "displayTime": "2026-01-11T22:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/5ef6c4c591b248a3412b0a0ddce16d95",
          "originalWidth": 1024,
          "originalHeight": 512,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0nbf7GAz1pqC3MjJDGb2gQ--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/5ef6c4c591b248a3412b0a0ddce16d95.cf.webp",
              "width": 1024,
              "height": 512,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zhEUBsdXIkyOKFrh_p9sEQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/5ef6c4c591b248a3412b0a0ddce16d95.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/tempus-achieves-record-total-contract-223000270.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/tempus-achieves-record-total-contract-223000270.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "4388.T"
            },
            {
              "symbol": "TEM"
            },
            {
              "symbol": "AZN"
            },
            {
              "symbol": "GSK"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NVS"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "DSKYF"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "WHWK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-11T21:54:00+00:00",
    "headline": "Eikon, a high-profile startup led by Merck vets, seeks an IPO",
    "summary": "Run by Roger Perlmutter and backed by more than $1 billion in private funding, Eikon will use the IPO proceeds to advance a group of experimental cancer drugs.",
    "url": "https://www.biopharmadive.com/news/eikon-ipo-file-cancer-tlr-parp-roger-perlmutter/809308/",
    "source": "BioPharma Dive",
    "provider": "yfinance",
    "raw": {
      "id": "0818bbca-1903-3989-9178-437ee2c5066d",
      "content": {
        "id": "0818bbca-1903-3989-9178-437ee2c5066d",
        "contentType": "STORY",
        "title": "Eikon, a high-profile startup led by Merck vets, seeks an IPO",
        "description": "",
        "summary": "Run by Roger Perlmutter and backed by more than $1 billion in private funding, Eikon will use the IPO proceeds to advance a group of experimental cancer drugs.",
        "pubDate": "2026-01-11T21:54:00Z",
        "displayTime": "2026-01-11T21:54:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/biopharma_dive_768/b9f85997c5b849adb7363f473dceb8df",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": " Nasdaq MarketSite headquarters in New York, N., on Aug. 21, 2022. ",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EiTWMILCyd7ftsGoiWs7xw--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/biopharma_dive_768/b9f85997c5b849adb7363f473dceb8df.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ME.cXH82JndUDBsRzyqHgQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/biopharma_dive_768/b9f85997c5b849adb7363f473dceb8df.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "BioPharma Dive",
          "url": "https://biopharmadive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.biopharmadive.com/news/eikon-ipo-file-cancer-tlr-parp-roger-perlmutter/809308/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eikon-high-profile-startup-led-215400651.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-11T16:03:00+00:00",
    "headline": "This ETF Is Proof That the Healthcare Rebound Is Real",
    "summary": "Track healthcare’s 2026 setup: GLP-1 drug adoption, a valuation gap vs. tech, and why VHT offers broad exposure with low fees and dividends.",
    "url": "https://www.marketbeat.com/originals/this-etf-is-proof-that-the-healthcare-rebound-is-real/?utm_source=yahoofinance&utm_medium=yahoofinance",
    "source": "MarketBeat",
    "provider": "yfinance",
    "raw": {
      "id": "021e66ae-183c-308d-8a24-6c4404ad6e5b",
      "content": {
        "id": "021e66ae-183c-308d-8a24-6c4404ad6e5b",
        "contentType": "STORY",
        "title": "This ETF Is Proof That the Healthcare Rebound Is Real",
        "description": "",
        "summary": "Track healthcare’s 2026 setup: GLP-1 drug adoption, a valuation gap vs. tech, and why VHT offers broad exposure with low fees and dividends.",
        "pubDate": "2026-01-11T16:03:00Z",
        "displayTime": "2026-01-11T16:03:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/marketbeat_955/d0b030cbc514357d4ca88578c9786536",
          "originalWidth": 1200,
          "originalHeight": 675,
          "caption": "Caduceus symbol on trading floor with rising stock charts, highlighting healthcare stocks and market momentum.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Hocz2O5hucEGA2l3AG6LkQ--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/marketbeat_955/d0b030cbc514357d4ca88578c9786536.cf.webp",
              "width": 1200,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RV6ZmN4p6FdLkswQuKrHdw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/marketbeat_955/d0b030cbc514357d4ca88578c9786536.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MarketBeat",
          "url": "https://www.marketbeat.com/"
        },
        "canonicalUrl": {
          "url": "https://www.marketbeat.com/originals/this-etf-is-proof-that-the-healthcare-rebound-is-real/?utm_source=yahoofinance&utm_medium=yahoofinance",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/etf-proof-healthcare-rebound-real-160300473.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "TSLA"
            },
            {
              "symbol": "HCA"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "VHCIX"
            },
            {
              "symbol": "VHT"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "CVS"
            },
            {
              "symbol": "UNH"
            },
            {
              "symbol": "ELV"
            },
            {
              "symbol": "NVO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]